開示日時：2022/05/17 15:00:00
損益
| 決算期 | 売上高 | 営業益 | 経常益 | EPS |
| 2018.03 | 110,742,900 | 9,923,200 | 8,951,800 | 133.58 |
| 2019.03 | 114,271,300 | 9,568,700 | 8,464,200 | 141.64 |
| 2020.03 | 112,925,400 | 8,776,900 | 7,930,000 | 128.23 |
| 2021.03 | 105,656,000 | 6,730,100 | 5,536,200 | 91.92 |
※金額の単位は［万円］
株価
| 前日終値 | 50日平均 | 200日平均 | 実績PER | 予想PER |
| 1,962.0 | 1,928.84 | 1,927.23 | 34.87 | 12.43 |
※金額の単位は［円］
キャッシュフロー
| 決算期 | フリーCF | 営業CF |
| 2018.03 | 3,253,500 | 8,227,200 |
| 2019.03 | 1,902,000 | 8,521,300 |
| 2020.03 | 3,542,000 | 9,264,700 |
| 2021.03 | 1,320,400 | 7,527,100 |
※金額の単位は［万円］
▼テキスト箇所の抽出
Press Release SEKISUI CHEMICAL CO., LTD. May 17, 2022 (Updated) Notice Concerning the Partial Revision of “Summary of Financial Results of Fiscal Year 2021 Ended March 31, 2022” SEKISUI CHEMICAL CO., LTD. is announcing that there has been a correction to the public disclosure document published on April 27, 2022. There have been no revisions to numerical data (XBRL data). This revision is due to the discovery of an error in the numerical breakdown of revenue breakdown information (information by geographic region) in the Summary of Financial Results of Fiscal Year 2021 １． Reason for Revision Ended March 31, 2022. ２． Content of Revision (Segment Information) I Segment Information Summary of Financial Results of Fiscal Year 2021 Ended March 31, 2022 (P.20) c. Information as to sales, profit (loss), assets and other items on each reportable segment Fiscal 2021 (April 1, 2021 to March 31, 2022) Revisions have been underlined in the following tables. Sales Japan Europe China Asia Others Sales Japan Europe China Asia Others (Millions of yen) Reportable Segments Housing (Note 1) UIEP HPP Medical Total Other (Note 1 and 2) Total 513,861 166,556 109,780 38,332 828,530 2,076 830,607 5,550 60,193 19,404 85,148 5,143 58,955 11,007 75,106 1,005 76,112 1,177 5,845 47,448 2,332 56,804 － 1,669 11,237 900 13,807 13 － 88 － 95,377 85,148 56,892 13,807 North America 14,074 64,749 16,539 95,364 Sales to third parties 515,038 198,840 352,365 88,516 1,154,761 3,183 1,157,945 152 12,936 6,443 0 19,533 1,761 21,294 Total 515,191 211,776 358,809 88,517 1,174,295 4,944 1,179,239 Intersegment sales or transfers (Millions of yen) Reportable Segments Housing (Note 1) UIEP HPP Medical Total Other (Note 1 and 2) Total 513,861 166,556 109,780 38,332 828,530 2,076 830,607 5,550 60,193 7,412 73,155 － 73,155 5,143 58,955 11,007 75,106 1,005 76,112 1,177 5,845 50,904 2,332 60,260 － 1,669 7,781 908 10,359 88 － 60,349 10,359 North America 14,074 64,749 28,523 107,348 13 107,361 Sales to third parties 515,038 198,840 352,365 88,516 1,154,761 3,183 1,157,945 Intersegment sales or transfers 152 12,936 6,443 0 19,533 1,761 21,294 Total 515,191 211,776 358,809 88,517 1,174,295 4,944 1,179,239 － － － － － －
